56,131 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Proficio Capital Partners LLC

Proficio Capital Partners LLC acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 56,131 shares of the health services provider’s stock, valued at approximately $510,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of TDOC. Jennison Associates LLC bought a new position in shares of Teladoc Health during the third quarter valued at $1,544,000. Massachusetts Financial Services Co. MA increased its stake in Teladoc Health by 477.1% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock valued at $3,397,000 after purchasing an additional 305,961 shares in the last quarter. Geode Capital Management LLC raised its holdings in Teladoc Health by 1.5% in the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock worth $36,042,000 after buying an additional 56,864 shares during the last quarter. Maple Rock Capital Partners Inc. bought a new position in shares of Teladoc Health in the third quarter worth approximately $11,291,000. Finally, Quantinno Capital Management LP lifted its stake in shares of Teladoc Health by 190.4% in the third quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider’s stock worth $1,709,000 after buying an additional 122,050 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on TDOC. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. The Goldman Sachs Group decreased their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Piper Sandler decreased their target price on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Finally, Oppenheimer lowered their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average target price of $11.26.

Teladoc Health Stock Up 3.1 %

Shares of TDOC stock opened at $8.43 on Monday. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $15.43. The stock has a market cap of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27. The company has a 50 day simple moving average of $10.42 and a two-hundred day simple moving average of $9.76.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares of the company’s stock, valued at $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.